The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
BRUIN CLL-321: A phase 3 open-label, randomized study of pirtobrutinib versus investigator’s choice of idelalisib plus rituximab or bendamustine plus rituximab in BTK inhibitor pretreated chronic lymphocytic leukemia/small lymphocytic lymphoma.
 
George Follows
Honoraria - Abbvie; AstraZeneca; Janssen Oncology; Lilly
Consulting or Advisory Role - Janpix Limited/Centessa Pharmaceuticals
Speakers' Bureau - Takeda
Travel, Accommodations, Expenses - Janssen Oncology; Takeda
 
John M. Burke
Consulting or Advisory Role - Abbvie; Adaptive Biotechnologies; AstraZeneca; Bayer; BeiGene; Bristol Myers Squibb; Constellation Pharmaceuticals; Epizyme; Genentech/Roche; Genmab; Kura Oncology; Kymera; Lilly; MorphoSys; Novartis; Nurix; Seagen; TG Therapeutics; Verastem
Speakers' Bureau - Beigene; Seagen
 
Sebastian Grosicki
No Relationships to Disclose
 
Christine Chen
Honoraria - Abbvie; AstraZeneca; BeiGene; Gilead Sciences; Janssen; Novartis; Sanofi
Consulting or Advisory Role - Abbvie; AstraZeneca; BeiGene; Bristol-Myers Squibb; Gilead Sciences; Janssen; Novartis; Sanofi
Speakers' Bureau - AstraZeneca; BeiGene; Bristol-Myers Squibb; Gilead Sciences; Janssen
Research Funding - Gilead Sciences
 
Alessandro Sanna
Consulting or Advisory Role - Janssen
Speakers' Bureau - Abbvie; AstraZeneca; Janssen
Travel, Accommodations, Expenses - Abbvie; Janssen
 
Lindsey Elizabeth Roeker
Stock and Other Ownership Interests - Abbott Laboratories (I); Abbvie (I)
Honoraria - Aptitude Health; DAVA Oncology; OncLive/MJH Life Sciences; Peerview; Pfizer; Prova Education; Vaniam Group
Consulting or Advisory Role - Abbvie; Ascentage Pharma; AstraZeneca; BeiGene; Janssen; Loxo/Lilly; Nurix; Pharmacyclics; Pharmacyclics; TG Therapeutics
Research Funding - Adaptive Biotechnologies (Inst); Aptose Biosciences (Inst); AstraZeneca (Inst); DAAN Biotherapeutics (Inst); Genentech (Inst); Loxo/Lilly (Inst); Pfizer (Inst); Qilu Puget Sound Biotherapeutics (Inst)
Travel, Accommodations, Expenses - Loxo/Lilly; Vaniam Group
 
Shuhua Yi
No Relationships to Disclose
 
Talha Munir
Consulting or Advisory Role - Abbvie; Alexion Pharmaceuticals; AstraZeneca; BeiGene; Janssen-Cilag; Roche; SOBI
Speakers' Bureau - Abbvie; Alexion Pharmaceuticals; AstraZeneca; Gilead Sciences; Janssen-Cilag; SOBI
Travel, Accommodations, Expenses - Abbvie; Alexion Pharmaceuticals; AstraZeneca; Janssen-Cilag
 
Fátima de la Cruz
Consulting or Advisory Role - Abbvie; AstraZeneca; BeiGene; Janssen; Kyowa Kirin
Speakers' Bureau - Abbvie; AstraZeneca; BeiGene; Janssen; Kyowa Kirin; Takeda
Expert Testimony - Takeda
Travel, Accommodations, Expenses - Abbvie; Janssen; Takeda
 
Emmanuelle Ferrant
Honoraria - Abbvie; AstraZeneca; Janssen-Cilag
Consulting or Advisory Role - Abbvie; Janssen
Travel, Accommodations, Expenses - Janssen-Cilag
 
Zoltán Mátrai
Honoraria - Abbvie; Janssen; Lilly
Consulting or Advisory Role - Abbvie; Lilly
Travel, Accommodations, Expenses - Abbvie
 
Paolo Ghia
Leadership - Abbvie; AstraZeneca; BeiGene; Bristol-Myers Squibb; Janssen; Loxo/Lilly; MSD; Roche
Honoraria - Abbvie; AstraZeneca; BeiGene; Bristol-Myers Squibb; Janssen; Loxo/Lilly; MSD; Roche
Consulting or Advisory Role - Abbvie; AstraZeneca; BeiGene; Bristol-Myers Squibb; Janssen; Loxo/Lilly; MSD; Roche
Research Funding - Abbvie; AstraZeneca; Bristol-Myers Squibb; Janssen
 
Wojciech Jurczak
Consulting or Advisory Role - AstraZeneca; BeiGene; Roche
Research Funding - Acerta Pharma; BeiGene; Epizyme; Janssen-Cilag; MEI Pharma; Morphosys; Roche; Sandoz-Novartis; Takeda; TG Therapeutics; TG Therapeutics
 
Francesc Bosch
Leadership - Abbvie; AstraZeneca; BeiGene; Celgene; Janssen; Lilly O.; Novartis; Roche; Takeda
Honoraria - Abbvie; AstraZeneca; Celgene/Bristol-Myers Squibb; Gilead Sciences; Janssen; Mundipharma; Novartis; Roche
Consulting or Advisory Role - Abbvie; AstraZeneca; BeiGene; Celgene/Bristol-Myers Squibb; Gilead Sciences; Janssen; Lilly O.; Mundipharma; Novartis; Roche; Takeda
Speakers' Bureau - Abbvie; AstraZeneca; Celgene/Bristol-Myers Squibb; Gilead Sciences; Janssen; Mundipharma; Novartis; Roche; Takeda
Research Funding - Abbvie; AstraZeneca; Celgene; Janssen; Karyopharm Therapeutics; Novartis; Roche; Takeda
Travel, Accommodations, Expenses - Abbvie; AstraZeneca; Celgene/Bristol-Myers Squibb; Janssen; Roche
Other Relationship - Abbvie; AstraZeneca; Celgene; Gilead Sciences; Janssen; Mundipharma; Novartis; Roche; Takeda
 
Marisa E. Hill
Employment - Loxo@Lilly
Stock and Other Ownership Interests - Lilly
Consulting or Advisory Role - Lilly
Patents, Royalties, Other Intellectual Property - I work for Loxo@Lilly
Travel, Accommodations, Expenses - Loxo/Lilly
 
Denise Wang
Employment - Loxo/Lilly
Stock and Other Ownership Interests - Lilly O.
 
Ananya Guntur
Employment - Loxo/Lilly
Stock and Other Ownership Interests - Lilly O.
 
Ching Ching Leow
Employment - Loxo/Lilly
Stock and Other Ownership Interests - Lilly O.
 
Jeff Porter Sharman
Employment - US Oncology Network
Consulting or Advisory Role - Abbvie; Acerta Pharma/AstraZeneca; Beigene; Beigene; Bristol-Myers Squibb; Genentech; Janssen Oncology; Lilly; Merck
Research Funding - Acerta Pharma (Inst); Celgene (Inst); Genentech (Inst); Gilead Sciences (Inst); Merck (Inst); Pharmacyclics (Inst); Seagen (Inst); Takeda (Inst); TG Therapeutics (Inst)
 
Paul M. Barr
Consulting or Advisory Role - Abbvie; AstraZeneca; Bayer; BeiGene; Bristol-Myers Squibb/Celgene; Genentech; Infinity Pharmaceuticals; Janssen; MEI Pharma; Merck; MorphoSys; Novartis; Pharmacyclics; Seagen; TG Therapeutics
Research Funding - AstraZeneca (Inst); Pharmacyclics (Inst)